ABBV/JNJ—FDA approves Imbruvica for cGVHD: http://www.prnewswire.com/news-releases/us-fda-approves-imbruvica-ibrutinib-as-first-approved-treatment-specifically-for-adults-with-chronic-graft-versus-host-disease-cgvhd----a-serious-potentially-life-threatening-condition----after-failure-of-one-or-more-lines-300498499.html